International Stem Cell Stock Probability of Future OTC Stock Price Finishing Under 0.0008

ISCO Stock  USD 0.10  0.01  9.09%   
International Stem's future price is the expected price of International Stem instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of International Stem Cell performance during a given time horizon utilizing its historical volatility. Check out International Stem Backtesting, International Stem Valuation, International Stem Correlation, International Stem Hype Analysis, International Stem Volatility, International Stem History as well as International Stem Performance.
  
Please specify International Stem's target price for which you would like International Stem odds to be computed.

International Stem Target Price Odds to finish below 0.0008

The tendency of International OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.0008  or more in 90 days
 0.10 90 days 0.0008 
near 1
Based on a normal probability distribution, the odds of International Stem to drop to $ 0.0008  or more in 90 days from now is near 1 (This International Stem Cell probability density function shows the probability of International OTC Stock to fall within a particular range of prices over 90 days) . Probability of International Stem Cell price to stay between $ 0.0008  and its current price of $0.1 at the end of the 90-day period is about 81.02 .
Given the investment horizon of 90 days the otc stock has the beta coefficient of 6.32 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, International Stem will likely underperform. In addition to that International Stem Cell has an alpha of 3.2106, implying that it can generate a 3.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   International Stem Price Density   
       Price  

Predictive Modules for International Stem

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as International Stem Cell. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of International Stem's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.1026.47
Details
Intrinsic
Valuation
LowRealHigh
0.000.0826.45
Details

International Stem Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. International Stem is not an exception. The market had few large corrections towards the International Stem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold International Stem Cell, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of International Stem within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
3.21
β
Beta against Dow Jones6.32
σ
Overall volatility
0.02
Ir
Information ratio 0.13

International Stem Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of International Stem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for International Stem Cell can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
International Stem is way too risky over 90 days horizon
International Stem has some characteristics of a very speculative penny stock
International Stem appears to be risky and price may revert if volatility continues
International Stem has high likelihood to experience some financial distress in the next 2 years
International Stem Cell currently holds 4.31 M in liabilities. International Stem Cell has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist International Stem until it has trouble settling it off, either with new capital or with free cash flow. So, International Stem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like International Stem Cell sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for International to invest in growth at high rates of return. When we think about International Stem's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 7.18 M. Net Loss for the year was (899 K) with profit before overhead, payroll, taxes, and interest of 4.24 M.
International Stem Cell currently holds about 586 K in cash with (1.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Roughly 54.0% of the company shares are held by company insiders

International Stem Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of International OTC Stock often depends not only on the future outlook of the current and potential International Stem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. International Stem's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares OutstandingM

International Stem Technical Analysis

International Stem's future price can be derived by breaking down and analyzing its technical indicators over time. International OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of International Stem Cell. In general, you should focus on analyzing International OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

International Stem Predictive Forecast Models

International Stem's time-series forecasting models is one of many International Stem's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary International Stem's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about International Stem Cell

Checking the ongoing alerts about International Stem for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for International Stem Cell help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
International Stem is way too risky over 90 days horizon
International Stem has some characteristics of a very speculative penny stock
International Stem appears to be risky and price may revert if volatility continues
International Stem has high likelihood to experience some financial distress in the next 2 years
International Stem Cell currently holds 4.31 M in liabilities. International Stem Cell has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist International Stem until it has trouble settling it off, either with new capital or with free cash flow. So, International Stem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like International Stem Cell sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for International to invest in growth at high rates of return. When we think about International Stem's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 7.18 M. Net Loss for the year was (899 K) with profit before overhead, payroll, taxes, and interest of 4.24 M.
International Stem Cell currently holds about 586 K in cash with (1.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Roughly 54.0% of the company shares are held by company insiders

Other Information on Investing in International OTC Stock

International Stem financial ratios help investors to determine whether International OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Stem security.